Market Analysis Digital Therapeutics Growth Potential to 2027 | Página 3

Global Digital Therapeutics Market to 2027
www.theinsightpartners.com
cases across the globe and also the segment is expected to grow with the fastest growth rate of 22.0% during the forecast
period, 2018 to 2025.
Distribution Channel Insights
On the basis of distribution channel, the digital therapeutics market is segmented into patients, providers, payers, and
employers. In 2017, the patients segment is expected to dominate the market based on the distribution channel
contributing a share of 39.2%. This is primarily attributed to growing prevalence for the need to self-monitor as well as
manage one’s health status. However, providers segment is anticipated to grow at a fastest growth rate of 21.3% during
the forecast period.
Strategic Insights
Product launch/update and partnerships were observed as the most adopted strategy in global digital therapeutics
industry. Few of the product approvals and partnerships made by the players in the market are listed below:
2017: In November, Propeller Health and Express Scripts entered into a partnership to provide Propeller’s FDA-cleared
digital solutions to Express Scripts to manage asthma or COPD.
2016: In November, Propeller Health received FDA approval for its Propeller platform for use with GSK’s Ellipta inhaler.
2018: In April, Canary Health entered into a partnership with NMRHCA to offer the Better Choices, Better Health (BCBH)
digital therapeutics program in New Mexico.
2016: In June, Canary Health partnered with Medtronic to expand their diabetes care offerings with Canary Health's self-
management suite for pre-diabetes, diabetes and related comorbidities.
Inquire for Discount at https://www.theinsightpartners.com/discount/TIPHC00002236
DIGITAL THERAPEUTICS – MARKET SEGMENTATION
By Application
 Diabetes
 Cardiovascular Diseases
 Central Nervous System (CNS) Disease
 Respiratory Diseases
 Smoking Cessation
 Musculoskeletal Diseases
 Other Applications
3